Profile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports

Simple item page
dc.contributor.authorSánchez, Adriana
dc.contributor.authordi Pace, María
dc.contributor.authorBrahm, Javier
dc.contributor.authorZapata, Rodrigo
dc.contributor.authorChirino, Ruby
dc.contributor.authorDávalos, Milagros
dc.contributor.authorMéndez-Sánchez, Nahum
dc.contributor.authorArrese, Marco
dc.contributor.authorSchinoni, María
dc.contributor.authorLucena, Isabel
dc.contributor.authorAndrade, Raúl
dc.date.accessioned2017-03-23T14:46:30Z
dc.date.available2017-03-23T14:46:30Z
dc.date.issued2014
dc.description.abstractNTRODUCTION: Drug-induced liver injury (DILI) remains a major problem for drug development and represents a challenging diagnosis for clinicians. The absence of specific biomarkers for diagnosing DILI precludes the availability of reliable data on the epidemiology of the disease. In this study we aimed to describe the features of idiosyncratic hepatotoxicity reports in Latin American countries. MATERIAL AND METHODS: A literature search was performed using the online version of MEDLINE, EMBASE, Scopus, Google Scholar and specific data bases from Latin America (LA) (Scielo, Lilacs) to identify any case report or case series of published DILI from 1996 to 2012. From 1996 to 2012, a total of 176 patients with DILI were published in LA, involving 53 suspicious drugs. The median age in the adult population of these patients was 55 years (17-82) with prevalence of women (67%). Among main therapeutic classes, the rank order was led by non-steroidal anti-inflammatory (61 cases) and systemic antibacterial drugs (37 cases). Nimesulide was the individual drug responsible for the highest number of cases (53), followed by cyproterone acetate (18), nitrofurantoin (17), antituberculous drugs (13) and flutamide (12). Thirty two percent of published cases evolved to acute liver failure (ALF), and half of the subjects required liver transplantation or eventually died. CONCLUSIONS: This study represents the first structured attempt to assess the spectrum of DILI profile in LA. The establishment of a Latin American registry to collect prospective DILI cases using a standardized protocol will advance our knowledge about idiosyncratic DILI in this region.
dc.format.extent1
dc.identifier.citationAnn Hepatol. 2014 Mar-Apr;13(2) p:231-239
dc.identifier.urihttp://hdl.handle.net/11447/1052
dc.identifier.urihttp://dx.doi.org/10.1016/S1665-2681(19)30886-5
dc.language.isoen_US
dc.publisherEdiciones Medicina y Cultura
dc.subjectDrug-induced acute liver failure
dc.subjectLiver toxicity
dc.subjectDILI
dc.subjectFulminant liver failure
dc.subjectHepatotoxicity
dc.titleProfile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports
dc.typeArtículo

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Profile of idiosyncratic drug induced liver injury in Latin America. An analysis of published reports.pdf
Size:
179.57 KB
Format:
Adobe Portable Document Format
Description:
Texto completo
Download

Collections

Artículos Medicina y Ciencias de la Salud

Implementado por OpenGeek Services